Evaluation of the Aortoseal™ for Sealing and Fixation of AAA Endovascular Grafts to Aortic Wall
Launched by ENDORON MEDICAL · Sep 3, 2024
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new device called the Aortoseal Endostapling System, which is designed to help securely attach a special type of graft (a tube used to repair blood vessels) to the wall of the aorta in patients with an abdominal aortic aneurysm (AAA). An AAA is a condition where the aorta, the main blood vessel supplying blood to the body, becomes enlarged and can be at risk of bursting. The trial is currently recruiting participants aged 65 to 74 who either have a qualifying AAA that can be treated with an endovascular graft or have already received one in the past.
If you or a loved one are considering participation, you can expect to undergo treatment involving this new device, which aims to ensure a better and more secure fit of the graft to the aorta. This could potentially lead to improved outcomes for patients with AAA. Participants will be closely monitored throughout the trial, and it's a chance to contribute to research that may benefit future patients.
Gender
ALL
Eligibility criteria
- • Subjects diagnosed with a qualifying AAA suitable for elective endovascular repair with Endovascular Graft System or have a previously placed endovascular graft.
About Endoron Medical
Endoron Medical is a pioneering clinical trial sponsor dedicated to advancing innovative medical solutions through rigorous research and development. With a focus on enhancing patient outcomes, Endoron Medical specializes in the development of cutting-edge therapeutic technologies and interventions across various medical fields. The organization is committed to maintaining the highest standards of clinical integrity and regulatory compliance, fostering collaborations with healthcare professionals and institutions to ensure the safe and effective delivery of its products. By prioritizing patient-centric approaches, Endoron Medical aims to drive transformative changes in healthcare through evidence-based practices and rigorous clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Dallas, Texas, United States
Plano, Texas, United States
Norfolk, Virginia, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported